CClinicalTrials.gg
Not yet recruitingNCT07849881Updated Sep 30, 2026

Artificial Intelligence-Based Automatic Recognition and Localization of Anatomical Sites in Colonoscopy

An observational study in Colonic Diseases, sponsored by Xiuli Zuo. Not yet recruiting. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Xiuli Zuo · Observational

Updated Sep 30, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Other
Enrollment
8,000
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study aims to develop, validate and evaluate an artificial intelligence-based system for real-time automatic localization of colorectal anatomical sites during colonoscopy and detection of colonoscopic inspection extent, so as to improve examination quality and the precision of lesion management. The hypothesis of this study is that a colonoscopic image recognition model built on deep convolutional neural networks can accurately extract intestinal anatomical features from endoscopic video frames. In prospective and retrospective independent validation cohorts, the artificial intelligence model is hypothesized to achieve an overall accuracy of no less than 85% for the multi-class anatomical site localization task across colonic segments, with an expected sensitivity of 90% and specificity of 85%. The model predictions are expected to be in high agreement with assessments by senior endoscopists, with an anticipated Kappa coefficient of 0.80. This will verify the technical feasibility and accuracy of deep learning-driven real-time anatomical localization during colonoscopy.

02

Conditions studied

  • Colonic Diseases

Browse trials for

03

In context

Colonic Diseases

142 studies on the registry are indexed under Colonic Diseases; 22 are open to participants now.

This study's planned enrollment of 8,000 is above the median of 170 across 48 observational studies indexed under Colonic Diseases.

Browse Colonic Diseases studies →

Lead sponsor

Xiuli Zuo is the lead sponsor of 10 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Participants aged 18-75 years scheduled for colonoscopy, with successful cecal intubation and adequate bowel preparation. Colonoscopic videos are collected to validate an AI system for real-time anatomical site recognition and localization.

Inclusion criteria

  1. Aged 18-75 years, male or female;
  2. Undergoing colonoscopy;
  3. Successful cecal intubation with the endoscope reaching the ileocecal valve;
  4. Adequate colonic cleansing, with a Boston Bowel Preparation Scale (BBPS) score ≥2 points in each of the three colonic segments.

Exclusion criteria

Exclusion Criteria:

  1. Reduced life expectancy;
  2. Active gastrointestinal bleeding;
  3. History of lower gastrointestinal tract surgery;
  4. Previous history of colorectal cancer or adenomas;
  5. Prior history of sessile serrated polyps greater than 10 mm in diameter;
  6. Ongoing chemotherapy or radiotherapy;
  7. Diagnosis of inflammatory bowel disease;
  8. Intestinal diseases identified during the current examination, including colorectal cancer, colorectal polyps and inflammatory bowel disease;
  9. Pregnant or lactating women, and participants unwilling to use contraception during the study;
  10. Other behaviours that may increase disease risk, such as heavy alcohol consumption and drug abuse;
  11. Participants unable or unwilling to provide written informed consent;
  12. Unclear colonoscopy videos;
  13. Incomplete colonoscopy videos.
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
8,000 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Interventions

  • OtherArtificial intelligence-based colonoscopic anatomical site recognition system

    This artificial intelligence system performs real-time automatic recognition and localization of colorectal anatomical sites and detects the colonoscopic inspection extent during colonoscopy. The model is built with deep convolutional neural networks and validated using endoscopic video frames.

06

What researchers measure

Primary outcomes

  1. Accuracy

    The percentage of samples in which the artificial intelligence model correctly identifies the corresponding intestinal anatomical sites across all endoscopic video frames, relative to the total sample size enrolled in the study. This metric reflects the overall classification accuracy of the model.

    Time frame: through study completion, an average of 1 year

  2. Sensitivity

    The proportion of all true positive samples annotated as a specific intestinal segment by endoscopy experts that are correctly identified as this segment by the artificial intelligence model. This metric primarily evaluates the model's ability to avoid missed detection of the target anatomical site.

    Time frame: through study completion, an average of 1 year

  3. F1-score

    To address the problem of "class imbalance" caused by variable colonoscopy examination time across different intestinal segments, this study adopts the F1-score for comprehensive evaluation. The calculation is performed as follows: first, the precision for a specific intestinal segment is obtained; then the harmonic mean of this precision and sensitivity is calculated. To assess overall performance, the arithmetic mean of the F1-scores for all intestinal segment classifications is finally computed (i.e., macro-averaged F1-score).

    Time frame: through study completion, an average of 1 year

  4. Macro-AUC

    The receiver operating characteristic (ROC) curve reflects the model's overall discriminative performance under different decision thresholds. For this multi-class classification task, the calculation proceeds as follows: each specific intestinal segment is treated as the positive class one by one; the corresponding ROC curve is plotted and the area under the curve (AUC) is calculated for each segment. Thereafter, the arithmetic mean of AUC values across all anatomical categories is computed to obtain the macro-averaged AUC, which serves as the composite metric for evaluating the overall multi-class discriminative ability of the model.

    Time frame: through study completion, an average of 1 year

07

Study locations

No study locations are listed for this record.

08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07849881
Lead sponsor
Xiuli Zuo
Responsible party
Xiuli Zuo (Professor, Chief Physician, Department of Gastroenterology, Shandong University) — Sponsor-investigator
First posted
Sep 30, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Jan 1, 2028 (estimated)
Completion
Mar 1, 2028 (estimated)
Last update
Sep 30, 2026
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion